Overexpression of EMMPRIN Isoform 2 Is Associated with Head and Neck Cancer Metastasis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of EMMPRIN Isoform 2 Is Associated with Head and Neck Cancer Metastasis
Authors
Keywords
Head and neck cancers, Metastasis, Cancer cell migration, Small interfering RNAs, Metastatic tumors, Gene expression, Mouse models, Secretion
Journal
PLoS One
Volume 9, Issue 4, Pages e91596
Publisher
Public Library of Science (PLoS)
Online
2014-04-05
DOI
10.1371/journal.pone.0091596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells
- (2013) Tomoki Sumida et al. BMC CANCER
- Cathepsin B: a potential prognostic marker for inflammatory breast cancer
- (2013) Mohamed A Nouh et al. Journal of Translational Medicine
- EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
- (2012) Géraldine Lescaille et al. BMC CANCER
- Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B
- (2012) Thomas H. Beckham et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Neurofilament Light Polypeptide in Head and Neck Cancer Chemoresistance
- (2012) B. Chen et al. MOLECULAR CANCER RESEARCH
- ErbB2-Driven Breast Cancer Cell Invasion Depends on a Complex Signaling Network Activating Myeloid Zinc Finger-1-Dependent Cathepsin B Expression
- (2012) Bo Rafn et al. MOLECULAR CELL
- The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer
- (2012) N. Denaro et al. ONCOLOGY
- Characterization of Basigin Isoforms and the Inhibitory Function of Basigin-3 in Human Hepatocellular Carcinoma Proliferation and Invasion
- (2011) C.-G. Liao et al. MOLECULAR AND CELLULAR BIOLOGY
- Extracellular Matrix Metalloproteinase Inducer Expression in Salivary Gland Tumors
- (2010) Zhi-Quan Huang et al. JOURNAL OF CRANIOFACIAL SURGERY
- Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study
- (2010) Paola Matarrese et al. Molecular Cancer
- EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2 -mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
- (2009) F. Bougatef et al. BLOOD
- Solution Characterization of the Extracellular Region of CD147 and Its Interaction with Its Enzyme Ligand Cyclophilin A
- (2009) Jennifer Schlegel et al. JOURNAL OF MOLECULAR BIOLOGY
- EMMPRIN expression in tongue squamous cell carcinoma
- (2009) Zhiquan Huang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
- (2008) László Herszényi et al. BMC CANCER
- Evolving role of uPA/uPAR system in human cancers
- (2008) Kathleen Dass et al. CANCER TREATMENT REVIEWS
- Basigin-2 Is a Cell Surface Receptor for Soluble Basigin Ligand
- (2008) Robert J. Belton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cysteine cathepsin proteases as pharmacological targets in cancer
- (2007) Carmela Palermo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started